# Quicksilver II Pilot Study

> **NCT07688135** · NA · NOT_YET_RECRUITING · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 18 (estimated)

## Conditions studied

- Stage II Rectal Cancer
- Stage III Rectal Cancer

## Interventions

- **PROCEDURE:** Direct-to-surgery (i.e., no neoadjuvant chemotherapy)
- **PROCEDURE:** Control Group

## Key facts

- **NCT ID:** NCT07688135
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-09
- **Final completion:** 2028-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07688135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07688135, "Quicksilver II Pilot Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07688135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*